Key Insights

Highlights

Treatment Research

2 treatments under study, led by Onabotulinum Toxin A

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04580238Phase 1Withdrawn

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Showing all 1 trials

Research Network

Common Treatments

  • Onabotulinum Toxin A1
  • Non Botox Based Standard Of Care Treatments For Headachemigraine1

Active Sponsors

  • University of Alberta1

Top Investigators

Related Conditions

  • Cerebral Venous Sinus Thrombosis1
  • Headache Migraine1
  • Hemorrhagic Stroke1
  • Reversible Cerebral Vasoconstriction Syndrome1
  • Stroke Cva Or Tia1

Activity Timeline